The global Anatomic Pathology Market size is expected to reach USD 34.66 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.08% from 2021 to 2028. The advent of technology in the instruments and the protocols used during the anatomic pathological procedures is anticipated to increase the adoption rate of advanced anatomic pathological instruments.
Market players are collaborating for the refurbishment
of pathology products by the incorporation of innovative disease diagnostic
models. In April 2021, Leica Biosystems collaborated with Paige, an AI-based
diagnostics company, for expanded access to computational pathology products
for translational and clinical research. Under this partnership, Paige’s
AI-enabled research software and Leica Biosystems’ digital pathology platform
were combined. This, in turn, accelerates investments in the up-gradation of
pathological equipment.
Pathology-training programs offered to pathologist
trainees by public and private entities drive the market. For instance, the
Accreditation Council for Graduate Medical Education accredited residency
programs for anatomic pathology provide education and training to individuals
via numerous teaching conferences.
The drug discovery and development application segment
are expected to witness the fastest growth over the forecast period due to the
shifting paradigm from conventional medicine to personalized medicine. This is
primarily due to the growing reliance on discoveries of putative biomarkers for
the development of personalized therapies. Ongoing pathology training programs
to ensure that the pathology residents are aware of the developments taking
place in the field of personalized medicine have also accelerated the
market growth.
North America held the largest revenue share in 2020
owing to a large number of funding programs by public agencies and the presence
of key players. Asia Pacific is expected to witness the fastest growth due to
the presence of multiple associations that are engaged in conducting pathology
training programs.
Key players are undertaking various strategic
initiatives such as mergers & acquisitions and new product development to
maintain their market presence. For instance, in May 2021, CellCarta acquired
Reveal Biosciences, an AI-based pathology firm. This acquisition is aimed at
expanding CellCarta’s offerings in AI-enabled multi-omic data analysis services
and applications.
Related Press Release@ Anatomic Pathology Market Report
Anatomic Pathology Market Report
Highlights
- By product and services, the consumables segment accounted for the
largest share in 2020. High availability, low cost, and a frequent
purchase rate of consumables contributed to the segment growth
- The instruments product and services segment is expected to witness
the fastest growth over the forecast period. Technological advancements in
instruments to minimize the risk of errors through the integration of
novel design are expected to drive the segment
- The disease diagnosis application segment dominated the market in
2020 owing to the increasing role of anatomic pathological tools in
identifying any anomalies that help diagnose a condition. The use of
biomarkers for tracking and identifying infections and diseases during
diagnostic processes is expected to boost the growth of the segment
- In terms of end use, the hospitals segment captured the largest
share in 2020 due to an increase in the hospitalization rate that
stimulates the adoption of pathological workflows for disease monitoring
and diagnosis
- The diagnostic laboratories end-use segment growth is facilitated
by the use of state-of-the-art laboratory equipment and instrumentation,
multiple electronic interfaces, and information systems
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment